5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis-Reference-Cited by-同舟云学术

5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis

Published:1987-06 Issue:6 Volume:92 Page:1894-1898
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Sutherland Lloyd R.,Martin Francois,Greer Scott,Robinson Malcolm,Greenberger Norton,Saibil Fred,Martin Thomas,Sparr Joseph,Prokipchuk Ed,Borgen Lowell

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference15 articles.

1. Sulphasalazine and salicylazosulphadimidine in ulcerative colitis;Baron;Lancet,1962

2. A controlled therapeutic trial of long-term maintenance treatment of ulcerative colitis with sulphasalazine;Dissanayake;Gut,1973

3. Salazyopyrin, a new sulfanilamide preparation;Svartz;Acta Med Scand,1942

4. An experiment to determine the active therapeutic moiety of sulphasalazine;Azad Khan;Lancet,1977

5. Colonic release of 5-aminosalicylic acid from an oral preparation in active ulcerative colitis;Dew;Br J Clin Pharmacol,1983

Cited by 618 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of fatigue with disease activity and clinical manifestations in patients with Crohn’s disease and ulcerative colitis: an observational cross-sectional study in the United States;Current Medical Research and Opinion;2024-08

2. Acute severe ulcerative colitis trials: the past, the present and the future;Gut;2024-06-04

3. Current Endoscopic Scoring Systems in Inflammatory Bowel Disease;Gastrointestinal Endoscopy Clinics of North America;2024-06

4. miR-30c affects the pathogenesis of ulcerative colitis by regulating target gene VIP;Scientific Reports;2024-02-12

5. Current and future development of nanocarbon and its biocomposites production;Advanced Nanocarbon Polymer Biocomposites;2024